"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Molecular diagnostics company Inflammatix has closed a $57 million funding round, which will support the company's plans for ...

Promoting high-quality opening-up has always been a major theme of China's economic development paradigm, analysts said. The new international services alliance set up in the Hainan FTP is only one of ...

Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...

Event offered participants essential knowledge on diabetes, focusing on key topics such as patient empowerment, innovative ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

Steed suggests that existing capacity issues among treatment centers could dampen the growth potential ... Moreover, the discontinuation of a feasibility study by Medtronic and the exploration of ...

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of ...

The 2024 State Scorecard on Women's Health and Reproductive Care was conducted by the Commonwealth Fund, a nonpartisan foundation that promotes a high-performing health care system. (Barbor, 9/16) CBS ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...